|
|
ASH 2011
The 53rd Annual Meeting of the American Society of Hematology (ASH) took place in San Diego, California December 10-13, 2011. The webcasts taped at the meeting are reports on the current status of some of the most interesting research in myeloma. Please be aware that at the time of posting, in some cases, the interviewees are reporting on interim data from incomplete clinical trials. Therefore not all the data presented are final results, and it is possible that results will be different when the data has matured with long-term follow-up. None of this research has yet been peer-reviewed and published in a medical journal.
|
|
|
|
|
Enrique M Ocio, MD
University Hospital of Salamanca
Salamanca, Spain |
|
|
|
|
|
Antonio Palumbo, MD
University of Torino
AOU S. Giovanni Battista
Torino, Italy |
|
|
|
|
|
Antonio Palumbo, MD
University of Torino
AOU S. Giovanni Battista
Torino, Italy
|
|
|
|
|
|
Antonio Palumbo, MD
University of Torino
AOU S. Giovanni Battista
Torino, Italy
|
|
|
|
|
|
Rakesh Popat, MD
UCL Cancer Institute
London, United Kingdom |
|
|
|
|
|
Andrzej J Jakubowiak, MD, PhD
University of Michigan
Ann Arbor, Michigan, USA |
|
|
|
|
|
María-Victoria Mateos, MD, PhD
Hospital Clinico Universitario
Salamanca, Spain |
|
|
|
|
|
Tomer M Mark, MD, MSc
Weill Cornell Medical College
New York, New York, USA |
|
|
|
|
|
Suzanne Lentzsch, MD, PhD
University of Pittsburgh School of Medicine and Cancer Institute
Pittsburgh, Pennsylvania, USA |
|
|
|
|
|
Sagar Lonial, MD
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia, USA |
|
|
|
step 1: get the correct diagnosis
publications
print
back to top